Endometriosis differs in location and invasive potential and can be found superficially on the peritoneum, in the ovaries as endometriotic cysts, and as deep infiltrating endometriosis affecting organs close to the pouch of Douglas, such as the rectovaginal septum and the rectosigmoid colon. 3 The etiology is still uncertain, but it is well known that endometriosis is an estrogen-dependent disease influenced by hormonal and inflammatory changes. [4] [5] [6] [7] [8] [9] Symptoms of endometriosis are dysmenorrhea, deep dyspareunia, chronic pelvic pain, and infertility, which affect these women's well-being physically, mentally, and socially. 10, 11 Treatment of endometriosis can either be surgical or medical, and the choice of treatment is based on individual woman's symptoms. Medical hormonal treatment is undesirable for women with endometriosis wishing to conceive due to the contraceptive effects of the hormonal treatments used.
From 10% to 25% of women with endometriosis require assisted reproductive technology (ART) to conceive. 12 During controlled ovarian stimulation, the estrogen level increases, in theory increasing the risk of the progression of symptoms related to endometriosis. Anaf et al identified four cases of rapidly growing sigmoid endometriosis during ovarian stimulation resulting in the cessation of ART and bowel surgery. 13 Eleven similar cases have occurred in our department since 2007. 14 Moreover, isolated cases with severe worsening of endometriosis during controlled ovarian stimulation have been described. [15] [16] [17] [18] The aim of this present study was to investigate whether the process of controlled ovarian stimulation during ART aggravates symptoms in women with endometriosis in terms of pain and quality of life (QoL).
| MATERIAL AND ME THODS
This prospective cohort study was carried out from February 2016
to October 2017. Participants were recruited from the Department of Obstetrics and Gynecology, Aarhus University Hospital, the Fertility Clinic at the Regional Hospital in Horsens, the Fertility Clinic at Aalborg University Hospital, and the private fertility clinic Maigaard Fertilitetsklinik, Aarhus, Denmark. Inclusion criteria were women < 40 years of age receiving controlled ovarian stimulation for in vitro fertilization (IVF) or intracytoplasmic sperm injection , who were able to understand and speak Danish. The participants were recruited regardless of previous infertility treatment of any kind. Participants were excluded during the course of the study if they were lost to follow up or if egg retrieval was cancelled.
On total, 177 women were distributed into three groups:
1. The exposed group: women with peritoneal/ovarian endometriosis or deep infiltrating endometriosis undergoing ART.
2. Reference group 1: women undergoing ART for factors other than endometriosis, eg male factor, tubal factor, and ovulation disorders.
3. Reference group 2: women with medically treated endometriosis, with no desire for pregnancy, hence not undergoing ART. Both women with newly diagnosed endometriosis and those with a satisfactory response to medical treatment were included.
For the exposed group and reference group 2 the diagnosis of endometriosis was confirmed by a previous laparoscopy, transvaginal ultrasound scan, or magnetic resonance imaging with no time limit, retrospectively, or by transvaginal ultrasound at the examination in connection with recruitment. Participants undergoing ART were recruited from the abovementioned fertility clinics, and reference group 2 was recruited from the endometriosis unit at the Department of Obstetrics and Gynecology, Aarhus University
Hospital.
Questionnaires were distributed via email (Appendix S1), and data were administered electronically in REDCap (Vanderbilt University, Nashville, TN, USA), which is a secure web application for building and managing online surveys and databases. The participants answered the same questionnaire at all time points with the exception of their baseline characteristics.
The exposed group and reference group 1 received the questionnaire before starting controlled ovarian stimulation and 10 days after egg retrieval. The second questionnaire was administered before knowing the pregnancy test result.
Reference group 2 received the first questionnaire immediately after consultation. In case of changes in the medical treatment, such as the use of oral contraceptives or intrauterine devices, the first questionnaire was postponed by 1 month to ensure stabilization.
The interval between first and second questionnaire was 4 weeks, corresponding to the gap between two questionnaires in the ART groups.
The questionnaire design was based on recommendations from the Art and Science of Endometriosis meeting. 
Key Message
This study examined endometriosis symptoms and quality of life during assisted reproductive technology. Our results found no worsening in these parameters, which supports the suitability of assisted reproductive technology as a therapeutic option for women with endometriosis suffering from infertility.
perceptions of characteristic endometriosis symptoms; non-menstrual pelvic pain, dyschezia, dyspareunia, and pain during micturition. The Wong-Baker FACES pain rating scale (Wong-Baker FACES Foundation, OK, USA) was used as a tool against with to compare the NRS in the questionnaire.
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Qualitative questions were asked relative to non-menstrual pelvic pain and dyspareunia. Frequency of pain symptoms was evaluated on a Likert-type scale (never, rarely, sometimes, often, and always). The degree of non-menstrual pelvic pain and dyspareunia was evaluated using questions inspired by the Biberoglu and
Behrman score. 22 The response categories for the most suitable statement for non-menstrual pelvic pain were "none," "mild: some loss in work efficiency," "moderate: in bed part of the day, occasional loss of work efficiency" and "severe: in bed one or more days, incapacitation" and for dyspareunia "none," "mild: tolerated discomfort"
"moderate: intercourse painful to the point of causing interdiction"
and "severe: avoids intercourse because of pain."
| Regimen of controlled ovarian stimulation
No fixed controlled ovarian stimulation protocols were used, as participants were treated individually. In general, two types of protocols were applicable: (a) antagonist protocol and (b) long agonist protocol.
Purified follicle-stimulating hormone or human menopausal gonadotropin was used for controlled ovarian stimulation in both protocols. Gonadotropin releasing hormone was used for downregulation during the long agonist protocol. Pregnancies were diagnosed by serum human chorionic gonadotropin > 10 IU/L or a positive urine human chorionic gonadotropin 14-16 days after oocyte aspiration or embryo transfer, depending on which fertility clinic the woman attended.
| Statistical analyses
According to a power analysis based on 10 as the smallest relevant difference in EHP-30 score, α = 0.05 and power (1−β) = 0.90, 48 participants needed to be recruited per group. Normality assumptions were confirmed using histograms and QQ-plots.
Continuous data on ART cycles were log-transformed where appropriate and described as mean and range or standard deviation, depending on whether the standard deviations were statistically different between the groups. The two ART groups were compared using t test or Wilcoxon signed-rank test depending on the distribution of the data. Categorical data on ART cycles were compared using chi-squared or Fisher's exact tests.
A change in parameters from the 1st to 2nd questionnaire was evaluated as the score in the 2nd questionnaire minus the score in the 1st. Hence, a positive change indicates a worsening in QoL. Changes in EHP-30 scores were analyzed using unpaired t test between the two groups undergoing ART and the two groups with endometriosis separately. For unequal standard deviations the Wilcoxon signed-rank test was used. ANOVA was performed for comparing continuous, normally distributed variables among all three groups. NRS parameters were described as median with minimum and maximum values and analyzed using the Kruskal- 
| Ethical approval
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| RE SULTS

| Population
During the study period, 177 women matched the criteria for inclusion in the three groups. During the study, participants were excluded because they refused to participate, cancelled egg retrieval, experienced a spontaneous pregnancy during downregulation or were lost to follow up. Ultimately, 154 women were retained for analysis ( Figure 1 ). Data on ART cycles (Table S1) of women in reference group 1 had then embryo transfer cancelled (P = 0.750). The reasons for infertility in reference group 1 were male factor (48%), tubal factor (13%), ovulatory dysfunction (4%), and other (35%).
| Pain
Baseline pain parameters (Table 2 ) differed between the groups.
Moreover, the groups differed in changes on the unadjusted parameters: tired, general, and worst non-menstrual pelvic pain (Tables 3   and 4 ). The groups with endometriosis experienced a median change of 0 in the factors tired and general non-menstrual pelvic pain compared with a change of 1 in the reference group 1 (P = 0.003 and P < 0.001, respectively). Regarding the worst non-menstrual pelvic pain, the median changes were 1 in the exposed group, 2.5 in reference group 1, and 0 in reference group 2, (P < 0.001). Adjustment for smoking, marital status and previous infertility treatment on the abovementioned parameters did not change the results (Table 5) .
Menstrual pain was not included, as most of the women undergoing ART were not menstruating, and a bleeding could well be an early miscarriage. Altogether 16 women with endometriosis undergoing ART had their period within the last 4 weeks in both questionnaires, and no significant difference in change was found between the groups. Additionally, only 14 women in reference group 2 had their period due to hormonal treatment (data not shown).
Changes in qualitative questions only differed between the groups in non-menstrual pelvic pain in terms of frequency and degree. Regarding degree, 44% of the exposed group experienced an increase of non-menstrual pelvic pain and 12% experienced a decrease. In reference group 1 52% experienced an increase and 12% a decrease, and in reference group 2 18% had an increase and 20% a decrease (P = 0.008). In terms of frequency, 50% of the exposed group experienced an increase and 23% a decrease, in reference group 1 58% experienced an increase and 8% a decrease, and in ref-
erence group 2 26% and 20% experienced an increase and decrease, respectively (P = 0.004).
| Quality of life
Baseline EHP-30 scores can be seen in Table 2 . All modules except for "self-image" were significantly higher in the exposed group than the reference group 1. Only the module "self-image" differed between the two endometriosis groups. In terms of changes in the five EHP-30 modules, significant differences were found between the exposed group and reference group 1 in all modules except selfimage. No statistically significant differences were found between the exposed group and reference group 2 (Tables 3 and 4 ). After adjusting for smoking, marital status and previous infertility treatment (Table 5 ), no differences were found between the two endometriosis Changes in pain or QoL within the groups according to different controlled ovarian stimulation protocols (agonist or antagonist) were evaluated and no systematic differences were found (data not shown).
| D ISCUSS I ON
The present study aimed to investigate whether controlled ovarian stimulation during ART aggravated pain and QoL already were used to a higher baseline pain level. Additionally, most women with endometriosis underwent downregulation during the long protocol that is known to reduce endometriosis symptoms.
However, the groups only differed by a maximum 1.5 point on the 0-10 NRS, hence it can be disputed that these changes are clinically cases with an uncontrolled design have described severely worsened endometriosis during ART 13, 15, 16, 18, 25, 26 especially in terms of bowel endometriosis, including 11 cases in our unit.
14 A strength of this study is the two reference groups, which allowed us to differentiate between changes in parameters caused by ART and endometriosis individually. Furthermore, the two endometriosis groups made it possible to use the disease-specific EHP-30.
It is known that a positive pregnancy test result affects treatment satisfaction 27 as well as QoL, 28 and hence the 2nd questionnaire was administered before the result of the pregnancy test was known.
This strength could nonetheless be limited by delayed answering The EHP-30 score uses a 0-100 scale, with 0 indicating the best health status to 100 indicating the worst. According to the different instructions of EHP-30, the −EMS/+ART and the +EMS/−ART groups were compared individually with the +EMS/+ART group using the Wilcoxon rank-sum test.
cycles showed that percentages of positive pregnancy tests and embryo transfers did not differ between the two ART groups (data not shown).
Our study included cycle data, which made it possible to correlate the questionnaire parameters with the hypothesis of worsening endometriosis owing to controlled ovarian stimulation. Despite significantly higher gonadotropin doses among the exposed group these women did not experience a greater worsening than the ref-
We consider the questionnaire compliance high, as 87% of the women recruited answered both questionnaires and only 4% ( 
| CON CLUS ION
This study did not show any worsening in endometriosis symptoms in terms of pain or QoL during ART. Hence it provides further support for ART as a suitable therapeutic option for infertile women with endometriosis. However, as we do not know the stage of endometriosis in the women in this study, we cannot rule out the possibility that worsening could be found in women with deep infiltrating endometriosis as most cases of worsening have been described among women with this endometriosis phenotype. Therefore, more research using controlled prospective trials is needed to investigate the long-term effects as well as the effect of ART on deep infiltrating endometriosis.
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TA B L E 5
Multivariate analysis for change parameters. All three groups were compared in the same multiple linear regression, with reference group 2 (+EMS/−ART) as the reference group 
NRS parameters
